Susquehanna International Group
AGIO icon

Susquehanna International Group’s Agios Pharmaceuticals AGIO Stock Holding History

Susquehanna International Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.2M Sell
94,500
-809,400
-90% -$22.9M ﹤0.01% 5150
2025
Q4 		$24.6M Buy
903,900
+736,300
+439% +$25.8M ﹤0.01% 2006
2025
Q3 		$6.73M Buy
167,600
+130,400
+351% +$4.9M ﹤0.01% 3622
2025
Q2 		$1.24M Buy
37,200
+600
+2% +$18.2K ﹤0.01% 6894
2025
Q1 		$1.07M Sell
36,600
-71,400
-66% -$2.37M ﹤0.01% 7086
2024
Q4 		$3.55M Buy
108,000
+101,800
+1,642% +$4.78M ﹤0.01% 4151
2024
Q3 		$275K Sell
6,200
-59,000
-90% -$2.68M ﹤0.01% 9789
2024
Q2 		$2.81M Buy
65,200
+7,800
+14% +$282K ﹤0.01% 4433
2024
Q1 		$1.68M Buy
+57,400
New +$1.54M ﹤0.01% 5747
2023
Q4 		– Sell
-58,500
Closed -$1.45M – 12266
2023
Q3 		$1.45M Buy
58,500
+17,500
+43% +$463K ﹤0.01% 5808
2023
Q2 		$1.16M Sell
41,000
-7,200
-15% -$179K ﹤0.01% 6339
2023
Q1 		$1.11M Buy
48,200
+35,000
+265% +$930K ﹤0.01% 6539
2022
Q4 		$371K Sell
13,200
-18,100
-58% -$510K ﹤0.01% 8596
2022
Q3 		$885K Buy
31,300
+12,500
+66% +$335K ﹤0.01% 6956
2022
Q2 		$417K Buy
18,800
+7,400
+65% +$167K ﹤0.01% 8719
2022
Q1 		$332K Sell
11,400
-79,100
-87% -$2.42M ﹤0.01% 10023
2021
Q4 		$2.98M Sell
90,500
-83,400
-48% -$3.36M ﹤0.01% 4657
2021
Q3 		$8.03M Sell
173,900
-26,600
-13% -$1.29M ﹤0.01% 3197
2021
Q2 		$11.1M Buy
200,500
+31,000
+18% +$1.73M ﹤0.01% 2764
2021
Q1 		$8.75M Sell
169,500
-65,400
-28% -$3.24M ﹤0.01% 2987
2020
Q4 		$10.2M Buy
234,900
+160,700
+217% +$6.35M ﹤0.01% 2475
2020
Q3 		$2.6M Sell
74,200
-46,500
-39% -$2.04M ﹤0.01% 4122
2020
Q2 		$6.46M Sell
120,700
-7,700
-6% -$357K ﹤0.01% 2670
2020
Q1 		$4.56M Sell
128,400
-117,700
-48% -$5.44M ﹤0.01% 2699
2019
Q4 		$11.8M Sell
246,100
-194,500
-44% -$7.35M ﹤0.01% 1910
2019
Q3 		$14.3M Buy
440,600
+222,700
+102% +$9.22M ﹤0.01% 1621
2019
Q2 		$10.9M Buy
217,900
+95,800
+78% +$5.12M ﹤0.01% 1796
2019
Q1 		$8.23M Sell
122,100
-8,400
-6% -$489K ﹤0.01% 1930
2018
Q4 		$6.02M Buy
130,500
+34,200
+36% +$2.11M ﹤0.01% 2087
2018
Q3 		$7.43M Sell
96,300
-51,500
-35% -$4.14M ﹤0.01% 2229
2018
Q2 		$12.4M Buy
147,800
+1,800
+1% +$157K ﹤0.01% 1717
2018
Q1 		$11.9M Buy
146,000
+56,600
+63% +$4.37M ﹤0.01% 1624
2017
Q4 		$5.11M Buy
89,400
+13,700
+18% +$862K ﹤0.01% 2513
2017
Q3 		$5.05M Sell
75,700
-57,100
-43% -$3.43M ﹤0.01% 2484
2017
Q2 		$6.83M Sell
132,800
-84,900
-39% -$4.34M ﹤0.01% 2047
2017
Q1 		$12.7M Buy
217,700
+23,600
+12% +$1.13M 0.01% 1414
2016
Q4 		$8.1M Buy
194,100
+23,400
+14% +$1.23M ﹤0.01% 1775
2016
Q3 		$9.02M Buy
170,700
+17,900
+12% +$780K ﹤0.01% 1605
2016
Q2 		$6.4M Buy
152,800
+61,700
+68% +$3.05M ﹤0.01% 1905
2016
Q1 		$3.7M Sell
91,100
-21,000
-19% -$898K ﹤0.01% 2728
2015
Q4 		$7.28M Sell
112,100
-13,300
-11% -$872K ﹤0.01% 2083
2015
Q3 		$8.85M Sell
125,400
-70,900
-36% -$6.93M ﹤0.01% 1968
2015
Q2 		$21.8M Sell
196,300
-3,700
-2% -$399K 0.01% 1231
2015
Q1 		$18.9M Buy
200,000
+41,900
+27% +$4.7M 0.01% 1279
2014
Q4 		$17.7M Sell
158,100
-2,100
-1% -$187K 0.01% 1447
2014
Q3 		$9.83M Buy
160,200
+129,200
+417% +$5.57M ﹤0.01% 2134
2014
Q2 		$1.42M Buy
+31,000
New +$1.26M ﹤0.01% 5342

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Susquehanna International Group's AGIO Position: Q1 2026 in Review

Susquehanna International Group increased its Agios Pharmaceuticals (AGIO) stake by 18% in Q1 2026, buying an estimated $5.74M and bringing the position to 1,344,953 shares worth $45.5M. The position accounts for 0.01% of the portfolio, ranked #1367.

Susquehanna International Group first reported a position in AGIO in Q2 2014 and has held it in 42 quarters since. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Susquehanna International Group held 1,344,953 shares of Agios Pharmaceuticals worth $45.5M as of Q1 2026.
  • Susquehanna International Group bought 202,521 Agios Pharmaceuticals shares in Q1 2026, an estimated $5.74M.
  • Agios Pharmaceuticals made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1367 holding.
  • Susquehanna International Group first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 42 quarters since.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.